BUXOCURE 40 Tablets contain Febuxostat, a xanthine oxidase inhibitor used in the management of hyperuricemia in patients with gout. It works by reducing the production of uric acid in the body, thereby helping to prevent gout flares and complications associated with elevated uric acid levels. It is commonly prescribed for long-term management of chronic gout.
Composition
Key Features & Benefits
- Effective Uric Acid Reduction: Lowers serum uric acid levels
- Gout Management: Helps prevent recurrent gout attacks
- Selective Action: Targets xanthine oxidase enzyme
- Long-Term Therapy: Suitable for chronic use
- Well-Tolerated: Trusted in clinical practice
Recommended Usage
- To be taken as prescribed by a healthcare professional
- Can be taken with or without food
- Follow the prescribed dosage and duration strictly
Safety Information
- Not recommended in patients with hypersensitivity to Febuxostat
- Use cautiously in patients with cardiovascular or liver conditions
- Monitor uric acid levels periodically
- Do not discontinue therapy without medical advice
Storage Instructions
- Store in a cool, dry place
- Protect from moisture and direct sunlight
- Keep out of reach of children
